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Background: Antenatal care is of core importance for maternal and child health and is therefore a central aspect of
mother and child health care. One of the main goals of effective screening in antenatal care is the detection of
suboptimal fetal growth. However, the sensitivity of antenatal diagnostic of suboptimal fetal growth (i.e. intrauterine
growth restriction; IUGR) through clinical routine fetal ultrasonography has been observed to be low. A study
conducted in Germany found that only 30% of IUGR cases and 40% of congenital malformations were diagnosed
antenatally. Reasons for this low detection rate remain unclear.
Methods/Design: In the first of two study components, all mothers who delivered or will deliver a small for
gestational age (SGA) newborn in one of three hospitals in Bremen (Germany) during recruitment phase are eligible
for inclusion in a hospital based case–control study. Cases are defined as neonates with an IUGR that was not
detected antenatally, while controls are defined as neonates whose IUGR was identified or at least suspected
antenatally. Data collection instruments include a newborn documentation sheet, a standardized, computer-assisted
personal interview with mothers, and a copy of pregnancy record books. The second component is a survey among
all private practice-based gynecologists in the federal states of Bremen and Lower Saxony. The aim of this survey
was to obtain detailed information e.g. on quality of ultrasonography equipment and examiner’s ultrasonography
experience and qualification level.
Discussion: To our knowledge, this is one of the few German studies explicitly addressing care-related as well
as maternal-related factors influencing the (non-) detection of IUGR by conducting comprehensive interviews
with mothers and private practice-based gynecologists. Over the last 15 years there have been substantial
technological advances in ultrasonography equipment in gynecological practices; hence there is the need to
evaluate whether the detection rates of IUGR in Germany are still as low as previously reported in the late
1990ies. Our study results will contribute to a better understanding of core risk factors for low early detection
rates of intrauterine growth restrictions and may support quality development in this important health care
sector.
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Early detection of intrauterine growth restriction (IUGR)
is of core importance for maternal and child health.
Pathological small for gestational age births (i.e. IUGR)
due to a pathological process are unable to reach their
growth potential, resulting in an increased risk for fetal
distress or fetal death during pregnancy or delivery [1-3].
Inadequate fetal growth is also associated with perinatal
morbidity and an elevated risk for delayed effects such
as chronic diseases in later life. These include cerebral
palsy, systolic hypertension and cardiovascular disease,
metabolic syndrome, obesity, insulin resistance and dia-
betes type II [4,5]. The incidence of IUGR in Western
Europe is approximately 3-8% of all pregnancies but the
diagnosis during pregnancy is rather suspected [6-8].
The majority of IUGR fetuses are SGA, defined as a
birth weight <10th percentile for gestational age. While
approximately 80-85% of the fetuses diagnosed as being
SGA are constitutionally small but healthy, 10-15% can
be identified as ‘true’ IUGR cases and the remaining 5-10%
are due to chromosomal anomalies or chronic intrauterine
infections [9].
However, because IUGR is a prenatal condition, SGA
at birth serves as a proxy measure for prenatal IUGR
[10]. Fetuses identified as SGA comprise a heteroge-
neous group with regard to underlying causes, manage-
ment and prognosis [11,12].
There are currently no effective therapies for the
treatment of IUGR. Its management during pregnancy
involves intensified fetal surveillance as well as choos-
ing the optimal time and method of delivery [5,13]. If
they still smoke, the affected women are advised to
stop or reduce smoking during the course of the preg-
nancy. To enable timely monitoring of these pregnan-
cies, it is important that suboptimal fetal growth is
detected early. Hence this is one of the main goals of
effective screening in antenatal care. In Germany,
ultrasonography is an essential part of antenatal care
and the main IUGR screening method used. According
to the maternity guidelines, three ultrasonography ex-
aminations should be routinely conducted during the
course of pregnancy. These examinations are typically
conducted by practice-based gynecologists. The guide-
lines also advise that women with suspected IUGR be
further examined using Doppler ultrasonography [8]
or be transferred to specialists or a hospital for con-
firmation of the diagnosis.
While studies on the efficacy of ultrasonography screen-
ing under study conditions reported high sensitivities of
80-90% for antepartal detection of IUGR [14,15], sen-
sitivity in clinical routine (effectiveness) in the late
1990ies and early 2000 was about 25-30% [16,17]. A
study conducted under routine service conditions in the
early 1990ies in Germany found that only 30% of caseswith IUGR and 40% of congenital malformations were
diagnosed antenatally [16,18]. Gynecologists in private
practice had the lowest detection rates. These findings
indicated that one of the main objectives of routine
screening in pregnancy may not be achieved, thereby
pointing out a quality problem in antenatal care in
Germany. Similar results have been reported for con-
genital malformations in Germany, with studies report-
ing an overall antenatal detection rate of 40% at best
[19-21]. Possible reasons for non-detection of IUGR
during pregnancy remain unclear. More evidence is
available on antenatal detection of congenital malfor-
mations, with a high correlation being observed between
the sensitivity of antenatal diagnosis and the type of
medical institution (e.g. practice-based gynecologists,
center for prenatal diagnosis or hospital), quality of the
ultrasonography equipment, as well as ultrasonography
experience and qualification level of the examiner
[22-28]. Studies conducted in Austria and Switzerland
reported detection rates of 22% for congenital mal-
formations in gynecological practices compared to ap-
proximately 90% in centers for prenatal diagnosis and
therapy [29,30]. A comprehensive review on the ef-
fectiveness of prenatal ultrasonography examinations
conducted by the Institute for Quality and Efficiency in
Health Care (IQWIG), Germany, confirmed the im-
portant influence of the quality of ultrasonography
equipment and the qualification of the investigator on
the antenatal detection of congenital malformations
[31]. However, only a few of the reviewed studies ex-
plicitly focused on these factors. The IQWIG clearly
expressed the need for analytical studies examining the
effect of the following factors on the antenatal detection
of diagnoses: examiner’s ultrasonography experience
and qualification level, and quality of ultrasonography
equipment.
Further factors that possibly influence the effectiveness
of ultrasonography screening in antenatal care are equity
of access to antenatal care and the actual process of care.
Several studies have reported differences in use and
timing of antenatal care and also indicated differences
in quality of care between women depending on social
class and migrant background. These differences may
result in an increased risk of unfavorable pregnancy
and birth outcomes for socially disadvantaged groups
[32-35]. Among those with a migrant background, factors
such as cultural and religious background, length of stay
in new country of residence, access to health care informa-
tion, differences in health systems between country of
origin and new country of residence, language profi-
ciency, education level and social status may also affect
their participation as well as the examination process
during antenatal care [36]. Using the quality of docu-
mentation of maternity records as a proxy indicator for
Ernst et al. BMC Pregnancy and Childbirth 2014, 14:371 Page 3 of 8
http://www.biomedcentral.com/1471-2393/14/371the quality of care, researchers in Germany observed
differences in the quality of antenatal care between
women of German and non-German nationality [37].
The completeness of anamnestic data and documenta-
tion of consultation were found to be lower among
women of non-German nationality than among German
women. Thus, in Germany, it can be assumed that the
documentation of prenatal diagnoses (e.g. IUGR) among
women with migrant background is of lower quality
than among those without migrant background, pos-
sibly resulting in insufficient surveillance of intrauterine
growth among the former.
Furthermore, an analysis of the national perinatal
registry in Germany showed a higher probability of
stillbirth in combination with SGA for women with mi-
grant background compared to German women [32].
As the associated risk factors for stillbirth were simi-
larly distributed in both groups, it can be assumed that
the observed stillbirth differences may be partly attrib-
uted to differences in the quality of antenatal care.
Up to now, most of the literature on antenatal diagno-
ses has focused on the detection of congenital malfor-
mations. Thus, there is a need to directly address IUGR
detection through dedicated investigations. The object-
ive of this paper is to describe the aims and study design
of the ongoing BIUS project, entitled “Care-related fac-
tors associated with antenatal diagnosis of intrauterine
growth restrictions – A case–control study”. The BIUS
project is funded by the German Federal Ministry of
Education and Research (BMBF).
Methods/Design
Aims of the study
The aim of this hospital-based case–control-study is
to identify care-related and maternal risk factors for
non-detection of intrauterine growth restrictions dur-
ing pregnancy. The study will also examine differences
in quality of care, course of treatment and access to
care in relation to maternal characteristics such as age,
parity, socio-economic status and migrant status.
The specific aims of the study are:
1. To describe the sensitivity of antepartal diagnosis of
IUGR and compare it with the reported low rates in
an earlier study by Jahn et al. in 1998 [16].
2. To identify care-related and maternal risk factors
(e.g. ultrasonography experience and qualification
level of examiner, type of medical institution, quality
of ultrasonography equipment, maternal smoking)
that are associated with an inadequate diagnosis and
treatment of IUGR during pregnancy.
3. To investigate if there are specific groups having a
higher chance of non-detected IUGR (e.g. women
with a migrant background).Study design
The ongoing BIUS study is a hospital-based case–
control study in which newborns that are SGA are
prospectively sampled. The recruitment of cases and
controls is carried out in cooperation with the obstetric
units of three hospitals in the federal city-state of Bremen,
Germany. The study region covers a geographical area
of 419.38 km2 with 654.774 residents and 5.657 deliver-
ies in 2012. Approximately 4.935 of these deliveries
were in the three cooperating hospitals, out of six hospi-
tals with an obstetric unit overall.
The study has two main components. In the first,
mothers of newborns that are SGA participate in com-
puter assisted personal interviews during which infor-
mation on pregnancy risk factors, uptake and quality of
prenatal care is collected. The second component is a
survey among all private practice-based gynecologists
in the federal states of Bremen and Lower Saxony. The
physician survey was also conducted in Lower Saxony
because a considerable proportion of the eligible women
who deliver their newborns in the participating hospitals
live in Lower Saxony. The aim of this survey is to gather
information on the physicians’ ultrasonography experi-
ence and qualification level as well as on the quality of
ultrasonography equipment. All gynecologists in the
federal states of Bremen and Lower Saxony were in-
formed about the study beforehand via hospitals, the
Ethics board of the Bremen Medical Association and
the media (Figure 1).
Case–control-definition and recruitment of participants
All women who delivered an SGA newborn from
01.01.2013 up to 30.06.2015 (*in one hospital the
recruitment period began on 01.08.2012) in one of the
participating obstetric units in Bremen are eligible for
the study and invited to participate. During the recruit-
ment period, SGA newborns are identified using two
independent approaches. Firstly, SGA is diagnosed by
the attending obstetricians based on the birth weight
in relation to gestational age, sex and findings and
symptoms at birth. Secondly, to avoid missing the diag-
nosis of any SGA newborn, all birth records as from
01.01.2013 are screened by the project team and infor-
mation on birth weight in relation to gestational age,
sex and findings and symptoms at birth is extracted.
We use a three stage approach to enroll study partici-
pants. After the initial information about the study,
women are contacted by mail through the study nurses
working in the hospital. Reminders are sent three
and six weeks after initial contact, including a non-
responder questionnaire after six weeks.
In compliance with routinely used growth references
for newborns in Germany [38], in both approaches SGA
is defined as birth weight <10th percentile for gestational
Identification of cases and controls in
obstetric units of cooperating hospitals
in Bremen
Standardized, Computer Assisted
Personal Interviews with mother sand
additional medical information from
pregnancy record books and newborn
documentation sheets
Survey among practice-based
gynecologists in Bremen and Lower
Saxony
Definition of newborns with SGA and (pathological)
IUGR by the hospital staff and study team members
Use of antenatal care, pregnancy and maternal
medical conditions, sociodemographic data(i.e.
socio-economic status,migrationbackground),
information on newborn child, e.g. gestational age
at birth, medical condition of newborn
Experience and qualification level of examiner, type













Direct contact by the study team (after
consent of mother through medical staff)
Contact by study team
Figure 1 Flow chart of study procedure and stages.
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fined as neonates with an undetected IUGR during
pregnancy and controls as neonates whose IUGR was
successfully identified antenatally. Newborns with sus-
pected IUGR documented in medical records are also
defined as controls. The final assignment to the case or
the control group, i.e. antenatally detected versus non-
detected IUGR, will be done taking further information
from the medical records and pregnancy record books
into account (e.g. condition and timing of IUGR diagno-
sis, date of birth, gestational age at birth, birth weight,
diseases and infections during pregnancy).
In line with local ethical and data protection require-
ments, mothers of all SGA newborns are initially in-
formed about the study by the attending obstetricians
during their hospital stay or via mail if they have already
left the hospital. The obstetricians obtain the initial con-
sent for the mothers to be contacted by the research
team. This process of enrolment is supported by several
study nurses who are employed at the cooperating hos-
pitals during the course of the study. Once the initial
written consent has been given, the mothers’ personal
identifying information is forwarded to the research
institute. Thereafter the mothers are provided with
detailed information on the study procedures and an
appointment for the personal interview is set.
As the obstetric units in Bremen cater for an ethnic
diverse population, study materials (i.e. study informa-
tion, study flyer) are available in Russian and Turkish,
the languages spoken by the two main migrant groups in
the region. Where required, the maternal interviews can
also be conducted in each of these languages.
Ethics statement and consent
Ethical approval for all study procedures was obtained
from the ethics review board of the Bremen Medical
Association. All women who deliver an SGA newbornin one of the cooperating hospitals receive written and
oral information about the study. All participating women
have to give written informed consent for data collection.
Data collection
Newborn documentation
All SGA newborns are identified during medical examina-
tions immediately after birth and/or through retrospective
screening of the birth record books. Basic information
such as birth weight, birth length and head circumference,
gestational age at birth and mode of delivery are docu-
mented by obstetricians or study nurses on a study-
specific newborn documentation sheet. Details on the
form and severity and timing of IUGR diagnosis (e.g.
antenatal vs. at birth) are added by the attending obstet-
rician or pediatrician in the hospital (Table 1).
Maternal survey
All mothers who consent to the study are interviewed
in the hospital shortly after delivery or at home should
they have already been discharged. The questionnaire is
designed as a standardized Computer Assisted Personal
or Telephone Interview (CAPI/CATI). To account for
different individual circumstances of each participating
woman after birth and selection bias (e.g. due to severity
of IUGR and that the mothers may want to focus their
full attention on their infants), we offer three interview
options, either a CAPI directly in the hospital, a CAPI
after birth at home or a CATI. The questionnaire, which
was developed in close collaboration with obstetric ex-
perts, covers aspects on socio-demographic informa-
tion, medical conditions and risk factors for IUGR
during pregnancy, as well as use, timing and content of
antenatal care (Table 1). Additionally, detailed informa-
tion on medical conditions, timing of antenatal care and
results of fetal ultrasonography during pregnancy is
available from the pregnancy record books that will be
Table 1 Data collection: source of information and variables concerning
Data source Field Variables concerning
Computer-assisted personal
Interview (CAPI)
General information Age*, Weight*, lengths*
CAPI; pregnancy record book Pregnancy and maternal medical
conditions
Weight gain during pregnancy, diseases and infections during pregnancy**,
number, time and reason for any hospitalization during pregnancy
CAPI Tobacco, coffee and substance
consumption
Smoking habits*, alcohol intake*, drug intake, coffee consumption
CAPI; pregnancy record book Use of antenatal care Number and time of antenatal care visits, Number and time of routine
ultrasonography, further examinations during pregnancy (specialists), parity
(live/stillbirth, miscarriages, etc.), type of medical institution
Pregnancy record book; newborn
documentation sheet
Newborn child Date of birth, sex, gestational age at birth, birth weight, birth lengths, head
circumference, APGAR score, mode of delivery, IUGR/SGA diagnosis, number




Marital status, migrant background, family size, school and professional
education, occupation, family income
Self-administered questionnaire
(physician survey)
Further care-related factors Quality of ultrasonography equipment, examiner’s ultrasonography experience
and qualification level, decision-making process, certificate for ultrasonography,
prenatal health information on IUGR
*Information on both mother and father.
**Confirmed by a doctor.
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institute. The interviews are conducted by trained pro-
ject personnel.
The whole study procedure was pre-tested among a
small sample of mothers prior to the recruitment phase.
All mothers who decline to participate in the study are
asked to fill in a short version of the questionnaire
containing socio-demographic and certain birth-related
data.
Survey among gynecologists
A physician survey among all gynecologists in Bremen
and Lower Saxony was conducted from January 2014 up
to July 2014. The gynecologists were pre-informed about
the survey through newsletters of the Association of
Statutory Health Insurance Physicians (Kassenärztliche
Vereinigung) in Bremen and Lower Saxony two weeks
before the initial survey contact. A total of 1,141 private
practice-based gynecologists in the two federal states
were asked to participate using a three stage approach
including written mail and email contact. The survey
comprised a self-administered web-based or paper ques-
tionnaire, containing 21 items covering aspects on the
gynecologists’ experience and qualification in ultrason-
ography, as well as the quality of the ultrasonography
equipment they use (Table 1).Table 2 Expected number of participants with IUGR based on
Hospital 1
Number of deliveries within 2½ years 5.763
IUGR (3-8%) 173-461
Response (50%) 87-231Expected number of participants during the recruitment
phase
According to data from 2012, the annual number of
deliveries in the three participating hospitals is approxi-
mately 4.935 (=12.339 deliveries in 2½ years). During
the course of the recruitment phase, we thus expect ap-
proximately 370 to 987 newborns with IUGR (3-8%)
(Table 2). Assuming a response rate of 50%, 185 to 494
cases can be included in this study (Table 2).
Data management and data analyses
At recruitment, each participating woman receives a
unique study identifier. This number is used to identify
her pseudonymised data and allows the linkage of all
collected information across the study, i.e. data from the
personal interview, the pregnancy record book and the
newborn documentation sheet. The interview data will
be directly transferred into the study database after the
interview. The study-specific newborn documentation
sheet is only transferred to the research institute if the
mother has given informed consent. Otherwise all data
remain in the hospitals. Data from the pregnancy record
book and the newborn documentation sheet are entered
into the study database by medical documentation spe-
cialists. Immediate automated data completeness and
plausibility checks are done. In addition, various strategies2012 data
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ness of routinely collected data, training of study team
members and of clinical and project staff are implemented
to maximize the quality of data collection.
The web-based responses of the physician survey were
automatically entered into the physician survey database,
while surveys returned by mail were manually entered
into the same software program by a research assistant.
The database of the physician survey and the database of
maternal interviews will be combined for statistical ana-
lyses at group level.
The study data will be analyzed using descriptive and
analytical approaches. Differences in socio-demographic,
pregnancy and birth related characteristics between cases
and controls, as well as between responders and non-
responders will be statistically tested using chi-square tests
for categorical variables or student’s t-test for continuous
variables. Associations between care-related or maternal
determinants and non-detection of IUGR will be exam-
ined in crude and multiple logistic regression models and
presented as odds ratios (OR) with 95% confidence
intervals (CI). In sensitivity analyses we will examine
differences in the applied method of case–control iden-
tification (patient record screening vs. identification by
obstetrician at birth) and apply different cut-off limits
for IUGR definition (i.e. birth weight <10th, <5th and <3rd
percentile for gestational age) to assess any changes in
detection rates.
Discussion
This study aims to evaluate antenatal detection-rates of
IUGR and to identify possible influencing factors asso-
ciated with non-detection of IUGR during pregnancy
by examining antenatal care routines in Germany, and
particularly the performance of fetal ultrasonography.
Furthermore, the study aims to identify possible high
risk groups for antenatal non-detection of IUGR in
terms of different social groups and according to mi-
grant background. To our knowledge, this is one of the
few German studies explicitly addressing care-related
as well as maternal-related factors influencing the (non-)
detection of IUGR by conducting comprehensive inter-
views with mothers and practice-based gynecologists.
Technological advances in ultrasonography equipment
have occurred over the last 15 years, and thus there is a
need to evaluate whether the detection rates of IUGR in
Germany are still as low as previously reported in the
late 1990ies. As already mentioned, results from studies
on congenital malformations suggest that the sensitivity
of antenatal diagnosis is highly correlated with the type
of medical institution, quality of the ultrasonography
equipment and examiner’s experience and qualification
level [22-28]. We will investigate if the same is true
for antenatal diagnosis of IUGR. Our study results willcontribute to a better understanding of core risk factors
for low early detection rates of IUGR and may provide a
better evidence basis for quality development in this
important health care sector.
While the term ‘small for gestational age’ refers to
neonates with a birth weight below the 10th percentile
and is not the same as IUGR, many publications use the
terms interchangeably [39,40]. There is no standard
definition of IUGR. In some publications it has been
defined as a birth weight <2 standard deviations below
the median for gestational age, whereas in others a
threshold of 3rd or 5th percentile of weight for age for
the given population is used [10,41]. For the purpose
of our study, we use percentile values for the German
population [38] to identify cases and controls. These
percentile values do not take the individual fetal
growth potential into account to differentiate between
physiological and pathological smallness (e.g. consider-
ing ethnicity, maternal weight and height) [42]. To our
knowledge customized growths charts are not available
for Germany so far. In order to deal with this potential
limitation, we will conduct sensitivity analyses with
different cut-off limits. According to literature, a true
IUGR is more likely with lower cut-off [43], thus we can
take risk differences between constitutionally SGA neo-
nates and clinically relevant IUGR into consideration.
Due to the relatively low incidence of IUGR (3-8%),
the recruitment of cases and controls in this study is a
particular challenge. Furthermore, the time available
for the recruitment of the individual mothers is very
limited as postpartum women usually stay in hospital
only for a short observation period. Another factor
which might influence response rates is severity of
IUGR. It is possible that mothers whose newborns have
severe IUGR will decline to participate in the study as
they will want to focus their full attention on their
infants. In addition, response bias might arise with par-
ents who are more engaged in their child’s health being
more willing to take part in the study. In an attempt to
address these issues we offer three interview options,
either a CAPI directly in the hospital, a CAPI after
birth at home or a CATI. We also implemented several
reminders and translated the study information and
the interview in different languages (i.e. Russian, Turkish)
to cater for the main migrant groups living in the study
region. A main strength of this study is that it relies on
study data from different hospitals that cover diverse
socio-economic settings in the federal state-city of
Bremen.
The interviews were pretested with mothers of neo-
nates who are diagnosed with SGA or IUGR in one of
the participating hospitals to ensure clarity and feasi-
bility of the interview questions, language, structure
and time needed.
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The present study evaluates the quality of antenatal
care and hopes to contribute further information to the
discussion of effectiveness of ultrasonography screen-
ing in relation to detection-rates of IUGR and to a
better understanding of influencing factors regarding
non-detection of IUGR. The results will be discussed
with the clinical partners, published in scientific journals
and presented at national and international conferences.
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